Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| AEOLUS PHARMACEUTICALS, INC. | 150 000 | déclaré | 08 mars 2013 | tx 5+177 027 |
| ROCKWELL MEDICAL, INC. | 80 000 | déclaré | 09 sept. 2022 | tx 3+830 000 |
| ALIMERA SCIENCES INC | 50 000 | déclaré | 21 nov. 2023 | tx 4+178 000 |
| Lineage Cell Therapeutics, Inc. | 24 078 | déclaré | 18 déc. 2018 | tx 10+485 750−45 422 |
| Processa Pharmaceuticals, Inc. | 10 758 | déclaré | 29 mai 2026 | tx 6+2 239 320 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 29 mai 2026 | PURCHASE | Processa Pharmaceuticals, Inc. | 2 292 | 2.57 USD | |
| 15 mai 2026 | PURCHASE | Processa Pharmaceuticals, Inc. | 1 984 | 2.97 USD | 1er après silence |
| 01 oct. 2025 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 324 000 | 0.00 USD | deriv |
| 01 oct. 2025 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 108 000 | 0.00 USD | deriv |
| 24 juil. 2025 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 1 775 044 | 0.00 USD | deriv |
| 16 juil. 2024 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 28 000 | 0.00 USD | deriv |
| 21 nov. 2023 | GRANT_AWARD | ALIMERA SCIENCES INC | 50 000 | 0.00 USD | deriv |
| 26 mars 2023 | GRANT_AWARD | ALIMERA SCIENCES INC | 58 000 | 0.00 USD | |
| 09 janv. 2023 | GRANT_AWARD | ALIMERA SCIENCES INC | 17 500 | 0.00 USD | |
| 09 janv. 2023 | GRANT_AWARD | ALIMERA SCIENCES INC | 52 500 | 0.00 USD | deriv |
| 09 sept. 2022 | GRANT_AWARD | ROCKWELL MEDICAL, INC. | 80 000 | 0.00 USD | deriv |
| 15 sept. 2020 | GRANT_AWARD | ROCKWELL MEDICAL, INC. | 600 000 | 0.00 USD | deriv |
| 15 sept. 2020 | GRANT_AWARD | ROCKWELL MEDICAL, INC. | 150 000 | 0.00 USD | deriv |
| 18 déc. 2018 | EXERCISE | Lineage Cell Therapeutics, Inc. | 22 500 | 0.00 USD | |
| 18 déc. 2018 | TAX_WITHHOLDING | Lineage Cell Therapeutics, Inc. | 7 781 | 1.03 USD | |
| 18 déc. 2018 | EXERCISE | Lineage Cell Therapeutics, Inc. | 22 500 | 0.00 USD | deriv |
| 04 oct. 2018 | TAX_WITHHOLDING | Lineage Cell Therapeutics, Inc. | 3 891 | 2.22 USD | |
| 04 oct. 2018 | EXERCISE | Lineage Cell Therapeutics, Inc. | 11 250 | 0.00 USD | |
| 04 oct. 2018 | EXERCISE | Lineage Cell Therapeutics, Inc. | 11 250 | 0.00 USD | deriv |
| 15 mars 2018 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 150 000 | 0.00 USD | deriv |
| 23 août 2017 | PURCHASE | Lineage Cell Therapeutics, Inc. | 2 000 | 2.64 USD | 1er après silence |
| 06 juin 2017 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 250 000 | 0.00 USD | deriv |
| 08 sept. 2016 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 50 000 | 0.00 USD | deriv |
| 08 mars 2013 | GRANT_AWARD | AEOLUS PHARMACEUTICALS, INC. | 150 000 | 0.00 USD | deriv |
| 23 mai 2012 | PURCHASE | AEOLUS PHARMACEUTICALS, INC. | 7 027 | 0.24 USD | 1er après silence |
3 achats déclarés après au moins 12 mois de silence — dernière occurrence le 15 mai 2026.